ArticleThe American journal of bioethics : AJOB2021

What Can We Learn from COVID-19 Drug Development and Access for Non-Pandemic Diseases? A Chinese Perspective.

Hui Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.